EZH2 is important for neuroblastoma cell survival by suppressing differentiation and tumor suppressors and for stabilizing the MYC oncoprotein [36,37,38,39,40], indicating that targeting EZH2 could be an alternative approach for neuroblastoma treatment. Here, MYC is linked to neuroblastoma.